MicroRNA-126 and epidermal growth factor-like domain 7 predict recurrence in patients with colon cancer treated with neoadjuvant chemotherapy.

Autor: Hansen TF; Danish Colorectal Cancer Center South, Vejle Hospital, Institute of Regional Health Research, University of Southern Denmark, Vejle 7100, Denmark., Carlsen AL; Department of Autoimmunology and Biomarkers, Statens Serum Institut, Copenhagen 2300, Denmark.; Department of Congenital Disorders, Statens Serum Institut, Copenhagen 2300, Denmark., Tanassi JT; Department of Autoimmunology and Biomarkers, Statens Serum Institut, Copenhagen 2300, Denmark., Larsen O; Department of Oncology, Herlev Hospital, Herlev 2730, Denmark., Sørensen FB; Danish Colorectal Cancer Center South, Vejle Hospital, Institute of Regional Health Research, University of Southern Denmark, Vejle 7100, Denmark.; University Institute of Pathology, Aarhus University Hospital, and department of Clinical Medicine, University of Aarhus, Aarhus 8200, Denmark., Jensen LH; Danish Colorectal Cancer Center South, Vejle Hospital, Institute of Regional Health Research, University of Southern Denmark, Vejle 7100, Denmark., Jakobsen A; Danish Colorectal Cancer Center South, Vejle Hospital, Institute of Regional Health Research, University of Southern Denmark, Vejle 7100, Denmark.

Publikováno v: Cancer drug resistance (Alhambra, Calif.) [Cancer Drug Resist] 2019 Sep 19; Vol. 2 (3), pp. 885-896. Date of Electronic Publication: 2019 Sep 19 (Print Publication: 2019).

Distinct proteome pathology of circulating microparticles in systemic lupus erythematosus.

Autor: Østergaard O; Department of Autoimmunology and Biomarkers, Statens Serum Institut, Copenhagen, Denmark., Nielsen CT; Copenhagen Lupus and Vasculitis Clinic, Centre for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Tanassi JT; Department of Autoimmunology and Biomarkers, Statens Serum Institut, Copenhagen, Denmark., Iversen LV; Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark., Jacobsen S; Copenhagen Lupus and Vasculitis Clinic, Centre for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Heegaard NHH; Department of Autoimmunology and Biomarkers, Statens Serum Institut, Copenhagen, Denmark.; Department of Clinical Biochemistry and Pharmacology, Odense University Hospital, University of Southern Denmark, Odense, Denmark.

Publikováno v: Clinical proteomics [Clin Proteomics] 2017 Jun 21; Vol. 14, pp. 23. Date of Electronic Publication: 2017 Jun 21 (Print Publication: 2017).

Quantification of Epidermal Filaggrin in Human Skin and its Response to Skin Irritation.

Autor: Bandier J; National Allergy Research Centre, Department of Dermato-Allergology, Copenhagen University Hospital Herlev and Gentofte, Hellerup, Denmark. Electronic address: Josefine.Bandier@regionh.dk., Ross-Hansen K; National Allergy Research Centre, Department of Dermato-Allergology, Copenhagen University Hospital Herlev and Gentofte, Hellerup, Denmark., Carlsen BC; National Allergy Research Centre, Department of Dermato-Allergology, Copenhagen University Hospital Herlev and Gentofte, Hellerup, Denmark., Tanassi JT; Department of Clinical Biochemistry, Immunology & Genetics, Statens Serum Institut, Copenhagen, Denmark., Johansen JD; National Allergy Research Centre, Department of Dermato-Allergology, Copenhagen University Hospital Herlev and Gentofte, Hellerup, Denmark., Heegaard NHH; Department of Clinical Biochemistry, Immunology & Genetics, Statens Serum Institut, Copenhagen, Denmark; Department of Clinical Biochemistry & Pharmacology, Odense University Hospital, University of Southern Denmark, Odense, Denmark.

Publikováno v: The Journal of investigative dermatology [J Invest Dermatol] 2016 Jun; Vol. 136 (6), pp. 1296-1299. Date of Electronic Publication: 2016 Feb 18.

Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study.

Autor: Kruse N; Department of Neuropathology, University Medical Center, Göttingen, Germany. Electronic address: n.kruse@med.uni-goettingen.de., Persson S; Clinical Neurochemistry Laboratory, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Sahlgrenska University Hospital, Mölndal, Sweden., Alcolea D; Department of Neurology, Institut Investigacions Biomediques, Hospital de Sant Pau, Barcelona, Spain; Centro de Investigación Biomédica en Red en enfermedades Neurodegenerativas-CIBERNED, Madrid, Spain., Bahl JM; Department of Autoimmunology & Biomarkers, Statens Serum Institut, Copenhagen S, Denmark., Baldeiras I; Neurochemistry Laboratory, Department of Neurology, Faculty of Medicine, CHUC-Centro Hospitalar e Universitário de Coimbra, CNC-Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal., Capello E; Department of Neuroscience (DINOGMI), Clinical Neurology Unit, Genoa, Italy., Chiasserini D; Centre for Memory Disturbances and Alzheimer's Centre-Laboratory of Clinical Neurochemistry, Department of Medicine, Section of Neurology, University of Perugia, Perugia, Italy., Bocchio Chiavetto L; Neuropsychopharmacology Unit, IRCCS Cento S. Giovanni di Dio Fatebenefratelli, Brescia, Italy; Faculty of Psychology, eCampus University, Novedrate (Como), Italy., Emersic A; Department of Neurology, University Medical Centre, Ljubljana, Slovenia., Engelborghs S; Reference Centre for Biological Markers of Dementia (BIODEM), Institute Born-Bunge, University of Antwerp, Antwerp, Belgium., Eren E; Department of Neuroscience, Health Science Institute, Dokuz Eylül University, Izmir, Turkey., Fladby T; Department of Neurology, Akershus University Hospital, Lørenskog, Norway., Frisoni G; Laboratory of Alzheimer´s Neuroimaging and Epidemiology, IRCCS Centro S. Giovanni di Dio Fatebenefratelli, Brescia, Italy; Departments of Psychiatry and Internal Medicine, University Hospitals and University of Geneva, Geneva, Switzerland., García-Ayllón MS; Centro de Investigación Biomédica en Red en enfermedades Neurodegenerativas-CIBERNED, Madrid, Spain; Instituto de Neurociencias de Alicante, Universidad Miguel Hernández-CSIC, Sant Joan d´Alcant, Spain., Genc S; Department of Neuroscience, Health Science Institute, Dokuz Eylül University, Izmir, Turkey., Gkatzima O; 3rd Neurology Department, Aristotle University of Thessaloniki, Thessaloniki, Greece., Heegaard NH; Department of Autoimmunology & Biomarkers, Statens Serum Institut, Copenhagen S, Denmark; Department of Clinical Biochemistry and Pharmacology, Odense University Hospital, Odense C, Denmark., Janeiro AM; Genomed, Diagnósticos de Medicina Molecular, Instituto de Medicina Molecular, Edificio Egas Moniz, Lisbon, Portugal., Kováčech B; Institute of Neuroimmunology, Slovak Academy of Sciences, Bratislava, Slovakia., Kuiperij HB; Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, Nijmegen, The Netherlands; Department of Laboratory Medicine, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, Nijmegen, The Netherlands., Leitão MJ; Neurochemistry Laboratory, Department of Neurology, Faculty of Medicine, CHUC-Centro Hospitalar e Universitário de Coimbra, CNC-Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal., Lleó A; Department of Neurology, Institut Investigacions Biomediques, Hospital de Sant Pau, Barcelona, Spain; Centro de Investigación Biomédica en Red en enfermedades Neurodegenerativas-CIBERNED, Madrid, Spain., Martins M; Instituto de Medicina Molecular, Edificio Egas Moniz, Lisbon, Portugal; Instituto Gulbenkian de Ciência, Oeiras, Portugal., Matos M; Instituto de Medicina Molecular, Edificio Egas Moniz, Lisbon, Portugal., Mollergard HM; Department of Neurology, Akershus University Hospital, Lørenskog, Norway., Nobili F; Department of Neuroscience (DINOGMI), Clinical Neurology Unit, Genoa, Italy., Öhrfelt A; Clinical Neurochemistry Laboratory, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Sahlgrenska University Hospital, Mölndal, Sweden., Parnetti L; Centre for Memory Disturbances and Alzheimer's Centre-Laboratory of Clinical Neurochemistry, Department of Medicine, Section of Neurology, University of Perugia, Perugia, Italy., de Oliveira CR; Neurochemistry Laboratory, Department of Neurology, Faculty of Medicine, CHUC-Centro Hospitalar e Universitário de Coimbra, CNC-Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal., Rot U; Department of Neurology, University Medical Centre, Ljubljana, Slovenia., Sáez-Valero J; Centro de Investigación Biomédica en Red en enfermedades Neurodegenerativas-CIBERNED, Madrid, Spain; Instituto de Neurociencias de Alicante, Universidad Miguel Hernández-CSIC, Sant Joan d´Alcant, Spain., Struyfs H; Reference Centre for Biological Markers of Dementia (BIODEM), Institute Born-Bunge, University of Antwerp, Antwerp, Belgium., Tanassi JT; Department of Autoimmunology & Biomarkers, Statens Serum Institut, Copenhagen S, Denmark., Taylor P; BioLegend, Inc., Dedham, MA, USA., Tsolaki M; 3rd Neurology Department, Aristotle University of Thessaloniki, Thessaloniki, Greece., Vanmechelen E; ADx NeuroSciences NV, Gent, Belgium., Verbeek MM; Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, Nijmegen, The Netherlands; Department of Laboratory Medicine, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, Nijmegen, The Netherlands., Zilka N; Institute of Neuroimmunology, Slovak Academy of Sciences, Bratislava, Slovakia., Blennow K; Clinical Neurochemistry Laboratory, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Sahlgrenska University Hospital, Mölndal, Sweden., Zetterberg H; Clinical Neurochemistry Laboratory, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Sahlgrenska University Hospital, Mölndal, Sweden; Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK., Mollenhauer B; Department of Neuropathology, University Medical Center, Göttingen, Germany; Paracelsus-Elena-Klinik, Kassel, Germany; Department of Neurosurgery, University Medical Center, Göttingen, Germany.

Publikováno v: Neurobiology of aging [Neurobiol Aging] 2015 Sep; Vol. 36 (9), pp. 2587-96. Date of Electronic Publication: 2015 May 15.

Filaggrin is a predominant member of the denaturation-resistant nickel-binding proteome of human epidermis.

Autor: Ross-Hansen K; National Allergy Research Centre, Department of Dermato-Allergology, Copenhagen University Hospital Gentofte, Hellerup, Denmark. Electronic address: katrine.ross-hansen@regionh.dk., Østergaard O; Department of Clinical Biochemistry, Immunology and Genetics, Statens Serum Institut, Copenhagen, Denmark., Tanassi JT; Department of Clinical Biochemistry, Immunology and Genetics, Statens Serum Institut, Copenhagen, Denmark., Thyssen JP; National Allergy Research Centre, Department of Dermato-Allergology, Copenhagen University Hospital Gentofte, Hellerup, Denmark., Johansen JD; National Allergy Research Centre, Department of Dermato-Allergology, Copenhagen University Hospital Gentofte, Hellerup, Denmark., Menné T; National Allergy Research Centre, Department of Dermato-Allergology, Copenhagen University Hospital Gentofte, Hellerup, Denmark., Heegaard NHH; Department of Clinical Biochemistry, Immunology and Genetics, Statens Serum Institut, Copenhagen, Denmark.

Publikováno v: The Journal of investigative dermatology [J Invest Dermatol] 2014 Apr; Vol. 134 (4), pp. 1164-1166. Date of Electronic Publication: 2013 Oct 24.